Bristol Myers Squibb (CELG-RI) Notes Payables (2009 - 2016)

Bristol Myers Squibb has disclosed Notes Payables across 8 years of filings, most recently posting $155.0 million for Q2 2016.

• In Q2 2016, Notes Payables fell 79.47% year-over-year to $155.0 million; the TTM figure through Jun 2016 stood at $155.0 million (down 79.47% YoY), while the FY2015 annual figure was $139.0 million, down 76.44% from the prior year.
• Notes Payables rose to $155.0 million in Q2 2016, from $106.0 million in the prior quarter.
• Over the last five years, Notes Payables for CELG-RI reached as high as $1.4 billion in Q1 2013 and fell as low as $106.0 million in Q1 2016.
• The 5-year median for Notes Payables is $383.0 million (2014), against an average of $494.3 million.
• Annual changes were most pronounced in 2013 — Notes Payables surged 846.21% — and 2014, when it sank 79.52%.
• A 5-year view of Notes Payables shows it stood at $826.0 million in 2012, then tumbled by 56.54% to $359.0 million in 2013, then surged by 64.35% to $590.0 million in 2014, then plunged by 76.44% to $139.0 million in 2015, then climbed by 11.51% to $155.0 million in 2016.
• According to Business Quant data, Notes Payables over the past three periods registered $155.0 million, $106.0 million, and $139.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.